There are 413 resources available
100P - Cost-Effectiveness Analysis of Trastuzumab Emtansine as Adjuvant Treatment for Patients in Singapore with Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Presenter: Elaine Lim
Session: Poster viewing and lunch
101P - Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
Presenter: Matteo Lambertini
Session: Poster viewing and lunch
102P - HER2DX risk-score in early-stage HER2-positive (HER2+) breast cancer: a correlative analysis of 757 patients from the Sweden Cancerome Analysis Network - Breast (SCAN-B) dataset
Presenter: Tomas Pascual
Session: Poster viewing and lunch
103P - Impact of Prosigna test on treatment decision in lymph node negative early breast cancer- a prospective multicenter study (EMIT1)
Presenter: Hege Ohnstad
Session: Poster viewing and lunch
104P - Obesity and recurrence in postmenopausal, estrogen-receptor positive breast cancer patients treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
Presenter: Karl Harborg
Session: Poster viewing and lunch
105P - Real-world systemic treatment choices and survival outcomes of patients diagnosed with non-metastatic high-risk HR+/HER2- breast cancer in the Netherlands
Presenter: Senna Lammers
Session: Poster viewing and lunch
106P - Perceptions, attitudes, and behaviors towards the risk of disease recurrence among women with HER2+ early breast cancer (eBC): ASKHER2 survey French cohort analysis
Presenter: Laure Gueroult-Accolas
Session: Poster viewing and lunch
107P - Results in Chinese patients from pre-planned overall survival interim analysis in monarchE: abemaciclib plus adjuvant endocrine therapy for high risk HR+, HER2- early breast cancer
Presenter: Zhimin Shao
Session: Poster viewing and lunch
108P - Safety results of post-neoadjuvant T-DM1 in the Italian compassionate use program (GIM26-TRASTHER study).
Presenter: Francesca Poggio
Session: Poster viewing and lunch
109P - Updated long-term overall survival of older adjuvant ibandronate-treated patients with intermediate- or high-risk early breast cancer compared with additional adjuvant capecitabine treatment - The ICE Randomized Clinical Trial
Presenter: Valentina Nekljudova
Session: Poster viewing and lunch